Finance

Lists
Why is RPGLIFE down 2.19%?
Dive Deeper
RPGLIFE:NSE
RPG Life Sciences Ltd
₹ 2,549.00
-2.19%
(-57.10) 1D
11-р сарын 20, 15:30:00 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RPGLIFE...
Open
₹ 2,600.00
High
₹ 2,615.90
Low
₹ 2,506.00
Mkt. cap
42.16 тэрбум
Avg. vol.
21.70 мян
Volume
5.99 мян
Dividend
0.94%
Quarterly dividend
₹ 6.00
Ex-dividend date
2026 оны 7-р сарын 9
P/E ratio
37.97
52-wk high
₹ 3,127.80
52-wk low
₹ 1,733.00
EPS
₹ 67.13
Shares outstanding
16.54 сая
No. of employees
1 мян
Open
₹ 2,600.00
High
₹ 2,615.90
Low
₹ 2,506.00
Mkt. cap
42.16 тэрбум
Avg. vol.
21.70 мян
Volume
5.99 мян
Dividend
0.94%
Quarterly dividend
₹ 6.00
Ex-dividend date
2026 оны 7-р сарын 9
P/E ratio
37.97
52-wk high
₹ 3,127.80
52-wk low
₹ 1,733.00
EPS
₹ 67.13
Shares outstanding
16.54 сая
No. of employees
1 мян
News stories
From web sources and news partners
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1.37 мян
Founded1993
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
2026 оны 10-р сарын 30
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
2.12 тэрбум / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
1.80 тэрбум
1.77 тэрбум
1.96 тэрбум
2.12 тэрбум
Cost of goods sold
649.00 сая
661.00 сая
681.50 сая
721.40 сая
Cost of revenue
649.00 сая
661.00 сая
681.50 сая
721.40 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
353.20 сая
570.90 сая
377.60 сая
440.90 сая
Operating expense
807.50 сая
835.00 сая
901.50 сая
1.06 тэрбум
Total operating expenses
1.46 тэрбум
1.50 тэрбум
1.58 тэрбум
1.78 тэрбум
Operating income
343.80 сая
273.30 сая
373.90 сая
336.20 сая
Other non operating income
34.10 сая
-101.90 сая
47.00 сая
42.60 сая
EBT including unusual items
291.20 сая
402.00 сая
414.60 сая
370.40 сая
EBT excluding unusual items
375.40 сая
277.30 сая
414.60 сая
370.40 сая
Income tax expense
69.90 сая
103.00 сая
107.00 сая
88.20 сая
Effective tax rate
24.00%
25.62%
25.81%
23.81%
Other operating expenses
400.50 сая
206.70 сая
464.90 сая
549.90 сая
Net income
221.30 сая
299.00 сая
307.60 сая
266.00 сая
Net profit margin
12.29%
16.90%
15.72%
12.57%
Earnings per share
-
-
-
-
Interest and investment income
-
96.70 сая
-
-
Interest expense
-2.50 сая
-3.90 сая
-6.30 сая
-8.40 сая
Net interest expenses
-2.50 сая
92.80 сая
-6.30 сая
-8.40 сая
Depreciation and amortization charges
53.80 сая
57.40 сая
59.00 сая
68.00 сая
EBITDA
395.75 сая
325.80 сая
426.40 сая
399.70 сая
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google аппс